Invascent
Kedaara buys majority stake in India dermatology player
Kedaara Capital has acquired a majority stake in medico-aesthetic dermatology services Oliva Skin & Hair Clinic, facilitating an exit for healthcare specialist InvAscent Capital.
Kedaara buys minority stake in India's Oasis Fertility
Kedaara Capital has invested USD 50m for a significant minority stake in Oasis Fertility, a fertility treatment business with more than 26 centres across India.
Creador, InvAscent invest $68m in India medical supplier
Malaysia-based Creador and Indian healthcare specialist InvAscent have invested a combined USD 68m in Indian medical equipment supplier Accumax Lab Devices.
India's MediBuddy gets $125m Series C
Quadria Capital and Lightrock India have led a USD 125m Series C round for Indian healthcare platform MediBuddy.
Fund focus: Emphasizing the partnership approach
Having raised $250 million for its third India healthcare fund, Invascent Capital plans to take advantage of a greater willingness among entrepreneurs to work with financial investors
Invascent closes India healthcare fund at $250m hard cap - update
Invascent Capital, an Indian healthcare-focused GP, has closed its third vehicle at the hard cap of $250 million.
Actis exits India's Symbiotec to MOPE, Invascent
Motilal Oswal Private Equity (MOPE) and healthcare-focused GP Invascent Capital have invested in Indian pharmaceutical developer Symbiotec Pharmalab, providing an exit for Actis Capital.
India healthcare: The growth infusion
Indian hospitals are increasingly attractive for private equity investors. GPs can thrive in the space with a well-defined growth strategy that takes local market requirements into account
KKR to invest about $150 million in India's Gland Pharma – report
KKR is reported to be in the process of buying around 30% of Gland Pharma, an active pharmaceutical ingredients and injectable drugs manufacturer, for $150 million.